Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("predictive markers")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 123

  • Page / 5
Export

Selection :

  • and

Proliferative markers as prognostic and predictive tools in early breast cancer : where are we now?COLOZZA, M; AZAMBUJA, E; CARDOSO, F et al.Annals of oncology. 2005, Vol 16, Num 11, pp 1723-1739, issn 0923-7534, 17 p.Article

Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia : the need for predictors and indicators of effectiveness has not abatedKATODRITOU, Eirini; ZERVAS, Konstantinos; TERPOS, Evangelos et al.British journal of haematology. 2008, Vol 142, Num 1, pp 3-10, issn 0007-1048, 8 p.Article

Clinical trial design for microarray predictive marker discovery and assessmentPUSZTAI, L; HESS, K. R.Annals of oncology. 2004, Vol 15, Num 12, pp 1731-1737, issn 0923-7534, 7 p.Article

Association between interleukin 10 gene polymorphisms and risk of type 2 diabetes mellitus in a Chinese populationHUA BAI; DANQING JING; AITAO GUO et al.Journal of international medical research. 2014, Vol 42, Num 3, pp 702-710, issn 0300-0605, 9 p.Article

Major haemorrhage related to surgery in patients with type I and possible type I von Willebrand diseaseWOODS, Adriana Inks; BLANCO, Alicia Noemi; CHUIT, Roberto et al.Thrombosis and haemostasis. 2008, Vol 100, Num 5, pp 797-802, issn 0340-6245, 6 p.Article

Association between interleukin 6 and interleukin 16 gene polymorphisms and coronary heart disease risk in a Chinese populationZICHUAN TONG; QIANG LI; JIANJUN ZHANG et al.Journal of international medical research. 2013, Vol 41, Num 4, pp 1049-1056, issn 0300-0605, 8 p.Article

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancerBERESFORD, M. J; HARRIS, A. L; AH-SEE, M et al.British journal of cancer. 2006, Vol 95, Num 12, pp 1683-1688, issn 0007-0920, 6 p.Article

HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinomaLIU, Y. J; SHEN, D; LIU, C et al.British journal of cancer. 2014, Vol 110, Num 5, pp 1169-1178, issn 0007-0920, 10 p.Article

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerYOUSEF, G. M; SCORILAS, A; MAGKLARA, A et al.British journal of cancer. 2002, Vol 87, Num 11, pp 1294-1300, issn 0007-0920, 7 p.Article

Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigensBEETON-KEMPEN, Natasha; DUARTE, Jessica; SHOKO, Aubrey et al.International journal of cancer (Print). 2014, Vol 135, Num 8, pp 1842-1851, issn 0020-7136, 10 p.Article

Neonatal protein kinase C zeta expression determines the neonatal T-Cell cytokine phenotype and predicts the development and severity of infant allergic diseaseD'VAZ, N; MA, Y; DUNSTAN, J. A et al.Allergy (Copenhagen). 2012, Vol 67, Num 12, pp 1511-1518, issn 0105-4538, 8 p.Article

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patientsMCGILVRAY, Roger W; EAGLE, Robert A; ROLLAND, Phil et al.International journal of cancer (Print). 2010, Vol 127, Num 6, pp 1412-1420, issn 0020-7136, 9 p.Article

Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancerLÜFTNER, Diana; HENSCHKE, Petra; FLATH, Bernd et al.Anticancer research. 2004, Vol 24, Num 2B, pp 895-906, issn 0250-7005, 12 p.Article

Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex CellSearch systemANDREOPOULOU, E; YANG, L.-Y; RANGEL, K. M et al.International journal of cancer (Print). 2012, Vol 130, Num 7, pp 1590-1597, issn 0020-7136, 8 p.Article

Impact of new prognostic markers in treatment decisions in acute myeloid leukemiaSCHLENK, Richard F; DÖHNER, Konstanze.Current opinion in hematology. 2009, Vol 16, Num 2, pp 98-104, issn 1065-6251, 7 p.Article

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistanceCLEATOR, Susan; TSIMELZON, Anna; CHANG, Jenny C et al.Breast cancer research and treatment. 2006, Vol 95, Num 3, pp 229-233, issn 0167-6806, 5 p.Article

Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver diseaseKANEDA, Hiroyuki; HASHIMOTO, Etsuko; YATSUJI, Satoru et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 9, pp 1459-1465, issn 0815-9319, 7 p.Article

Gene expression profiling in breast cancer : towards individualising patient managementMURPHY, N; MILLAR, E; LEE, C. S et al.Pathology (Sydney). 2005, Vol 37, Num 4, pp 271-277, issn 0031-3025, 7 p.Article

Targeted therapy for triple-negative breast cancer: Where are we?DUFFY, Michael J; MCGOWAN, Patricia M; CROWN, John et al.International journal of cancer (Print). 2012, Vol 131, Num 11, pp 2471-2477, issn 0020-7136, 7 p.Article

Radiotherapy response in oral squamous carcinoma cell lines : Evaluation of apoptotic proteins as prognostic factorsROBERG, Karin; JONSSON, Ann-Charlotte; GRENMAN, Reidar et al.Head & neck. 2007, Vol 29, Num 4, pp 325-334, issn 1043-3074, 10 p.Article

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancerYOUSEF, George M; SCORILAS, Andreas; NAKAMURA, Terukazu et al.Breast cancer research and treatment. 2003, Vol 78, Num 2, pp 149-158, issn 0167-6806, 10 p.Article

Number of Negative Points : A novel method for predicting radiosensitivity in head and neck tumor cell linesFARNEBO, Lovisa; JERHAMMAR, Fredrik; VAINIKKA, Linda et al.Oncology reports. 2008, Vol 20, Num 2, pp 453-461, issn 1021-335X, 9 p.Article

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patientsCORTES-FUNES, H; GOMEZ, C; ALBEROLA, V et al.Annals of oncology. 2005, Vol 16, Num 7, pp 1081-1086, issn 0923-7534, 6 p.Article

Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinomaPROPPER, D; DAVIDENKO, I; BRIDGEWATER, J et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1384-1390, issn 0923-7534, 7 p.Article

ERCC5/XPG, ERCC1, and BRCA1 Gene Status and Clinical Benefit of Trabectedin in Patients With Soft Tissue SarcomaITALIANO, Antoine; LAURAND, Armelle; COINDRE, Jean-Michel et al.Cancer. 2011, Vol 117, Num 15, pp 3445-3456, issn 0008-543X, 12 p.Article

  • Page / 5